TrialBeacon
CNClinicalTrials.govClinical trialActive, not recruiting

Development and Clinical Application of ApoC3 Protein as a Predictive Biomarker for Insulin Resistance in Polycystic Ovary Syndrome

Official record

Identifier
NCT07739953
Recruiting locations

country

China
Interventions studied
observational study
Lead sponsor
Guangdong Women and Children Hospital
Target enrolment
200 participants
Study type
OBSERVATIONAL
Phase
Not provided in the official record
Status
Active, not recruiting
First posted
Jul 31, 2026
Last updated on the registry
Jul 31, 2026
Age
16 Years – 45 Years
Sex
FEMALE
Study contact
No public contact is listed on the official record.
Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

I. Diagnostic Criteria

The 2003 Rotterdam diagnostic criteria for PCOS jointly established by the European Society of Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM):

Clinical and/or biochemical signs of hyperandrogenism; Oligo-ovulation or anovulation; Ultrasound findings: ovarian volume ≥ 10 mL, and/or \> 12 follicles with a diameter of 2-9 mm in a single section.

A diagnosis of PCOS can be established when at least two of the following three criteria are met: ovarian dysfunction, hyperandrogenism, and polycystic ovarian morphology on ultrasound.

II. Inclusion and Exclusion Criteria

1. PCOS with Insulin Resistance (PCOS-IR)

   Inclusion Criteria:

   Meets the 2003 Rotterdam diagnostic criteria for PCOS (at least 2 of the following 3 items):

   ① Oligo-ovulation or anovulation;

   ② Clinical or biochemical signs of hyperandrogenism;

   ③ Polycystic ovaries on ultrasound (unilateral or ovarian volume ≥ 10 mL).

   Insulin resistance (IR), meeting at least 1 of the following 3 criteria:

   ① HOMA-IR ≥ 2.5;

   ② Fasting insulin ≥ 15 μIU/mL;

   ③ Diagnosed impaired glucose tolerance (IGT) or type 2 diabetes mellitus (T2DM).

   Exclusion Criteria:

   Other endocrine disorders; Medication effects; Severe systemic diseases; Special physiological conditions (e.g., pregnancy, lactation); Poor sample quality.
2. PCOS without Insulin Resistance (PCOS-non-IR)

Inclusion Criteria:

Meets the PCOS diagnostic criteria (as above), with HOMA-IR \< 2.5 and no glucose metabolism abnormalities.

Exclusion Criteria: Same as above.

This site does not provide medical advice

TrialBeacon only aggregates links to publicly available official information. It does not recommend, rank or evaluate any treatment, trial or medicine, and nothing here implies suitability for any individual. Please discuss anything you find with your treating doctor, and always rely on the original official page — records change over time. Full disclaimer.